+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cannabidiol"

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 94 Pages
  • Global
From
Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 109 Pages
  • Global
From
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 110 Pages
  • Global
From
Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018 - Product Thumbnail Image

Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 30 Pages
  • Global
From
Sleep Aids in South Africa - Product Thumbnail Image

Sleep Aids in South Africa

  • Report
  • October 2023
  • 21 Pages
  • South Africa
From
Sleep Aids in Mexico - Product Thumbnail Image

Sleep Aids in Mexico

  • Report
  • October 2023
  • 24 Pages
  • Mexico
From
Sleep Aids in Bulgaria - Product Thumbnail Image

Sleep Aids in Bulgaria

  • Report
  • October 2023
  • 22 Pages
  • Bulgaria
From
Sleep Aids in Poland - Product Thumbnail Image

Sleep Aids in Poland

  • Report
  • September 2023
  • 25 Pages
  • Poland
From
Sleep Aids in Ireland - Product Thumbnail Image

Sleep Aids in Ireland

  • Report
  • September 2023
  • 21 Pages
  • Ireland
From
Sleep Aids in Colombia - Product Thumbnail Image

Sleep Aids in Colombia

  • Report
  • September 2023
  • 23 Pages
  • Colombia
From
Sleep Aids in France - Product Thumbnail Image

Sleep Aids in France

  • Report
  • September 2023
  • 24 Pages
  • France
From
Sleep Aids in Greece - Product Thumbnail Image

Sleep Aids in Greece

  • Report
  • September 2023
  • 23 Pages
  • Greece
From
Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Switzerland - Product Thumbnail Image

Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Switzerland

  • Report
  • July 2023
  • 33 Pages
  • Switzerland
From
Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Spain - Product Thumbnail Image

Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Spain

  • Report
  • June 2023
  • 30 Pages
  • Spain
From
Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Slovakia - Product Thumbnail Image

Smokeless Tobacco, E-Vapour Products and Heated Tobacco in Slovakia

  • Report
  • June 2023
  • 29 Pages
  • Slovakia
From
2024 Global Forecast for Cannabidiol (2025-2030 Outlook) - High Tech & Emerging Markets Report - Product Thumbnail Image

2024 Global Forecast for Cannabidiol (2025-2030 Outlook) - High Tech & Emerging Markets Report

  • Report
  • January 2024
  • 132 Pages
  • Global
From
Cannabidiol in Neurology and Psychiatry. International Review of Neurobiology Volume 177 - Product Thumbnail Image

Cannabidiol in Neurology and Psychiatry. International Review of Neurobiology Volume 177

  • Book
  • July 2024
Loading Indicator

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease. CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions. The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more